Pilot study to test the efficacy and safety of activated recombinant factor VII (NovoSeven) in the treatment of refractory hemorrhagic cystitis following high-dose chemotherapy

被引：0
|
作者：
A A Ashrani
D A Gabriel
J L Gajewski
D R Jacobs
D J Weisdorf
N S Key
机构：
[1] University of Minnesota,Department of Medicine
[2] University of North Carolina,Department of Medicine
[3] MD Anderson Cancer Center,Department of Medicine
[4] University of Minnesota,Department of Epidemiology
[5] Mayo Clinic College of Medicine,Department of Internal Medicine, Division of Hematology
[6] Fox Chase – Temple University,Bone Marrow Transplant Program
[7] University of North Carolina,Department of Medicine, Division of Hematology
来源：
Bone Marrow Transplantation | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：825 / 828
页数：3
相关论文
共 50 条
  • [31] EFFICACY AND SAFETY OF RITUXIMAB AND HIGH-DOSE DEXAMETHASONE (R-DEX) IN THE TREATMENT OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA
    Simkovic, M.
    Belada, D.
    Motyckova, M.
    Zak, P.
    Smolej, L.
    HAEMATOLOGICA, 2013, 98 : 542 - 543
  • [32] A single dose of recombinant activated factor VII (NovoSeven®) did not impair the function of the coronary artery bypass grafts -: Successful treatment of critical bleeding after cardiac surgery in two cases
    Pfau, Giselher
    Schilling, Thomas
    Kozian, Alf
    Huth, Christof
    Schneemilch, Christine E.
    Heim, Marcell U.
    TRANSFUSION MEDICINE AND HEMOTHERAPY, 2007, 34 (03) : 204 - 207
  • [33] HIGH-DOSE ALPHA-2-RECOMBINANT INTERFERON IN THE TREATMENT OF MALIGNANT LYMPHOPROLIFERATIVE DISEASES - A PILOT-STUDY
    OPAT, P
    DRBAL, J
    VYZULA, R
    NEOPLASMA, 1989, 36 (04) : 489 - 494
  • [34] Recombinant factor VIIa [(rFVIIa) NovoSeven®by single dose for home treatment of joint bleeds in hemophilia patients with inhibitors:: A pilot, double-blind study versus standard multiple doses of NovoSeven® and an activated prothrombin complex concentrate [aPCC (FEIBA®].
    Young, Guy
    BLOOD, 2006, 108 (11) : 89B - 89B
  • [35] DEFICIENCY OF FIBRINOGEN AND FACTOR-VII FOLLOWING TREATMENT OF SEVERE APLASTIC-ANEMIA WITH ANTITHYMOCYTE GLOBULIN AND HIGH-DOSE METHYLPREDNISOLONE
    FISCHER, M
    LECHNER, K
    HINTERBERGER, W
    NIESSNER, H
    PABINGER, I
    DUDCZAK, R
    NEUMANN, E
    KORNINGER, C
    DEUTSCH, E
    SCANDINAVIAN JOURNAL OF HAEMATOLOGY, 1985, 34 (04): : 312 - 316
  • [36] Efficacy and safety of high-dose chemotherapy as second or subsequent salvage therapy in relapsed or refractory germ cell cancer patients: A multicentric analysis
    Seidel, C.
    De Giorgi, U. F. F.
    Engel, N.
    Hentrich, M.
    Zschaebitz, S.
    Conolly, E.
    Weickhardt, A. J.
    Grimison, P.
    Wong, V.
    Oing, C.
    Alsdorf, W.
    Schaefers, C.
    Bokemeyer, C.
    Tran, B.
    ANNALS OF ONCOLOGY, 2023, 34 : S503 - S503
  • [37] A multicenter, observational study to evaluate hemostasis following recombinant activated FVII treatment in patients in Japan with congenital factor VII deficiency
    Seita, Ikuo
    Kinai, Ei
    BLOOD COAGULATION & FIBRINOLYSIS, 2023, 34 (05) : 295 - 304
  • [38] MITOXANTRONE HIGH-DOSE ARA-C AND RECOMBINANT HUMAN GM-CSF IN THE TREATMENT OF REFRACTORY NON-HODGKINS-LYMPHOMA - A PILOT-STUDY
    HO, AD
    DELVALLE, F
    ENGELHARD, M
    HIDDEMANN, W
    RUCKLE, H
    SCHLIMOK, G
    HAAS, R
    THIEL, E
    ANDREESEN, R
    FIEDLER, W
    FRISCH, J
    SCHULZ, G
    HUNSTEIN, W
    CANCER, 1990, 66 (03) : 423 - 430
  • [39] Combined treatment of metastatic breast cancer (MBC) by high-dose chemotherapy (HDCT) and bispecific antibodies: A pilot study
    Stemmler, HJ
    Salat, C
    Lindhofer, H
    Menzel, H
    Untch, M
    Kahlert, S
    Konecny, G
    Sauer, H
    Ledderose, G
    Heinemann, V
    Kolb, HJ
    ANTICANCER RESEARCH, 2005, 25 (04) : 3047 - 3054
  • [40] Efficacy and safety of prothrombin complex concentrate and recombinant activated factor VII versus placebo in a rabbit model of hemodilution, bleeding and thrombosis: a blind study
    Le Sache, F.
    Le Bonniec, B.
    Dizier, B.
    Godier, A.
    Bachelot-Loza, C.
    Emmerich, J.
    Samama, C. M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 449 - 450
12345